Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

A business case for evidence-based veterinary medicine
Evidence based
Richard Killen believes that having EBVM guidelines within a practice could help younger vets plan treatment more easily.

Debate considers how EBVM can improve veterinary practices 

Today's clinical decision making requires taking into account an ever-increasing pool of scientific data. The evidence-based medicine (EBM) approach to clinical care has revolutionised patient care in human medicine and there is now a widespread appetite to extend this to the veterinary world.

At the beginning of a debate on the business case for evidence-based veterinary medicine at the VPMA and SPVS Congress (27-28 January), Graham Milligan reported on an RVC research project, which aimed to identify its commercial benefits. After his presentation, a panel of experts - including Mark Harwood, Richard Killen and Alan Robinson - gave their views before the debate was thrown open to the floor.

All three panellists agreed that EBVM could improve the business of veterinary practices, suggesting that EBVM would help to streamline case decisions thereby reducing time and staffing. Richard Killen suggested that it would also improve a practice's recruitment and vet retention potential.

Richard believes that having EBVM guidelines within a practice could help younger vets plan treatment more easily. This would reduce the potential for possible complaints and the consequent stress this can generate.

Alan was asked if the idealist EBVM translated into the pragmatism of the consulting room. He felt that the increased confidence, technical help and ability to follow accepted standards would all be a massive advantage to veterinary surgeons. He also said that it would definitely make good business sense for recruitment and retention.

From the floor, Bradley Viner commented that practising good medicine has a strong financial benefit as well as improving practice culture.

The ‘Google' effect was also discussed, with the panel pointing out that over 50 per cent of complaints relate to clients expecting treatments to be carried out as a result of their reading on Google.

Richard Killen felt that by adopting EBVM, the ‘Google effect' could be counteracted because practices will be able to say that they are following 'best accepted EBVM procedures'.

The panel were asked how EBVM would work on the ground - and it was felt that RCVS Knowledge could help considerably with this.

They were also questioned on whether large corporates would use their own significant pool of clinical information in place of the 'official' EBVM. If a practice did not follow what was considered to be the 'official' EBVM, would insurance companies not pay for a pet's treatment? The panel felt that the veterinary profession had enough strength to prevent this kind of situation.

One member of the audience asked: 'How do you know you are practising EBVM’? This brought up the question of how EBVM would be presented to the profession and how it would be accessed, how much there would be and how much time veterinary surgeons would need to spend to stay up to date.

Another delegate commented that it is also important to have evidence on the more fundamental issues, such as catheter placement, as well as the more esoteric operations and treatment.

There is clearly a long way to go before EBVM is used in all practices. There are issues of how it will be accessed and adhered to, but the general consensus is that there is most definitely a business case. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.